MarketBeat on MSN

Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA's AI Favorite?

CompanyOverview|NASDAQ:RXRX] Recursion Pharmaceuticals' (NASDAQ: RXRX) stock price has seen a dramatic increase, not due to ...
The Globe and Mail

Recursion Pharmaceuticals’ Earnings Call Highlights Progress and Challenges

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The recent earnings call for Recursion ...
GEN

Recursion’s CEO Discusses Pipeline Growth, Approach to AI and ML

For years, drug developers that apply artificial intelligence (AI) have touted the benefits of the technology—the prospect of speedier development of new treatments at lower cost, thus reducing the ...
The Globe and Mail

Recursion Pharmaceuticals’ Earnings Call Highlights Growth and Challenges

Recursion Pharmaceuticals, Inc. recently held its earnings call, which conveyed an optimistic sentiment. The company is experiencing strong leadership transitions, maintaining a robust financial ...